RSS

investment

Provider of products and research services, Envigo, has announced it is investing in an expansion of its surgical facility located in Livermore, California, USA, in response to rising demand from West Coast companies. more

News

Pharmaceutical outsourcing services provider, PCI Pharma Services, has announced the expansion of analytical laboratories at its centre of excellence for contained manufacturing in Tredegar, UK. more

Technology

Global contract pharmaceutical development and manufacturing organisation (CDMO), Almac Group, has completed a £20 million investment in its cold chain management capabilities with the opening of a facility in Northern Ireland. more

News

UK-based synthetic biology company, Prokarium, has completed an investment round, raising $10 million for the clinical development of vaccines against chlamydia, C.difficile and enteric fever, plus an expansion for the immune-oncology R&D team more

News

NHS England initiative, SBRI Healthcare, has revealed which companies will benefit from its investment of £8.7 million — aimed at advancing the development of novel technologies to future-proof primary care and GP services. more

News

Debiopharm Group, international biopharmaceutical group, has continued its efforts in the fight against antibiotic resistance by investing in antibiotic development through acquiring a minority stake in ABAC Therapeutics. more

News

Specialty biopharmaceutical group, Ferring Pharmaceuticals, has announced its 30 million CHF investment in its new biotech centre in Switzerland. more

News

Specialist in data discovery, knowledge graphs, search and data interaction, Siren, has completed a seed round worth €3 million, which it will use to bring its semantic data investigation platform to new sectors, including life sciences. more

Technology

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex, has revealed that it will be investing in the expansion of chemical and analytical development capabilities at its Charles City, Iowa plant more

News

International pharmaceutical outsourcing services provider, PCI Clinical Services, has received the green light to begin operations in its newly expanded European Clinical Services Centre of Excellence. more

News

Engineering consultancy and automation expert, 3P innovation, has announced its plans to expand its UK operations through a new purpose-built facility that will accommodate its next phase of investment and growth. more

News

Sanofi and Regeneron have revealed that they will accelerate and expand investment for the clinical development programmes of cemiplimab in oncology and dupilumab in type 2 allergic diseases. more

News

Recipharm has taken a step further in its development and growth in the Indian market by acquiring the remaining shares in Nitin Lifesciences. more

News

With the industry experiencing dramatic change, from regulatory changes to investments in capacity and the uncertainty of the political landscape, we asked several industry heads to review the opportunities, challenges and trends of 2017. more

Opinion

The Association of the British Pharmaceutical Industry (ABPI) has released research showing that the amount of capital invested alongside corporate venture capital (CVC) in UK biotech increased six-fold between 2010 and 2015. more

Analysis

European life sciences investment group, LSP has successfully raised €280 million in funding, which will be used to invest in private companies with innovative healthcare products in the field of medical devices, diagnostics and digital health. more

News

SGS, a bio/pharmaceutical analytical and bioanalytical contract solutions provider, has launched new large molecule bioanalytical services at its laboratory in Wavre, Belgium. more

News

Science-led global healthcare company, GlaxoSmithKline (GSK) has welcomed the UK government’s announcement of the Life Sciences Sector Deal, by announcing £40 million investment in genomic research. more

News

Ahead of the government’s announcement of its industrial strategy, it has been revealed that MSD (also known as Merck) will make a landmark investment into the UK’s economy through the opening of a new UK hub, for the research into future treatments. more

News

UK based fund manager, Sixth Element Capital, has announced a £3 million investment in a spin out company from PhoreMost — NeoPhore. more

News